BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets

被引:127
作者
MacLachlan, TK
Takimoto, R
El-Deiry, WS
机构
[1] Univ Penn, Howard Hughes Med Inst, Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Lab Mol Oncol & Cell Cycle Regulat, Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Med, Sch Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Genet, Sch Med, Philadelphia, PA 19104 USA
[5] Univ Penn, Dept Pharmacol, Sch Med, Philadelphia, PA 19104 USA
[6] Univ Penn, Ctr Canc, Sch Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/MCB.22.12.4280-4292.2002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pathway leading to BRCA1-dependent tumor suppression is not yet clear but appears to involve activities in DNA repair as well as gene transcription. Moreover, it has been shown that BRCA1 can regulate p53-dependent transcription. Because BRCA1 overexpression stabilizes wild-type p53 but does not lead to apoptosis of most cell lines, we investigated the selectivity of BRCA1 for p53-dependent target gene activation. We find that BRCA1-stabilized p53 regulates transcription of DNA repair and growth arrest genes while p53 stabilized by DNA-damaging agents induces a wide array of genes, including those involved in apoptosis. This differential expression profile was reflected in the treatment outcome-apoptosis following DNA damage and growth arrest after expression of BRCA1. Depletion of BRCA1 in wild-type-p53-expressing cells abolished the induction of such repair genes as p53R2, while the expression of PIG3, an apoptosis-inducing gene, was still induced. BRCA1 also conferred diminished cell death in a p53-dependent manner in response to adriamycin compared to that conferred by controls. These results suggest that BRCA1 selectively coactivates the p53 transcription factor towards genes that direct DNA repair and cell cycle arrest but not towards those that direct apoptosis.
引用
收藏
页码:4280 / 4292
页数:13
相关论文
共 54 条
  • [1] BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair
    Abbott, DW
    Thompson, ME
    Robinson-Benion, C
    Tomlinson, G
    Jensen, RA
    Holt, JT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) : 18808 - 18812
  • [2] Tumor suppressor p53 is required to modulate BRCA1 expression
    Arizti, P
    Fang, L
    Park, I
    Yin, YX
    Solomon, E
    Ouchi, T
    Aaronson, SA
    Lee, SW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (20) : 7450 - 7459
  • [3] Attardi LD, 2000, GENE DEV, V14, P704
  • [4] Bates S, 1996, ONCOGENE, V13, P1103
  • [5] Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells
    Chen, JJ
    Silver, DP
    Walpita, D
    Cantor, SB
    Gazdar, AF
    Tomlinson, G
    Couch, FJ
    Weber, BL
    Ashley, T
    Livingston, DM
    Scully, R
    [J]. MOLECULAR CELL, 1998, 2 (03) : 317 - 328
  • [6] Redistribution of BRCA1 among four different protein complexes following replication blockage
    Chiba, N
    Parvin, JD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) : 38549 - 38554
  • [7] BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
    Couch, FJ
    DeShano, ML
    Blackwood, MA
    Calzone, K
    Stopfer, J
    Campeau, L
    Ganguly, A
    Rebbeck, T
    Weber, BL
    Jablon, L
    Cobleigh, MA
    Hoskins, K
    Garber, JE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (20) : 1409 - 1415
  • [8] Cressman VL, 1999, CELL GROWTH DIFFER, V10, P1
  • [9] p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours
    Crook, T
    Brooks, LA
    Crossland, S
    Osin, P
    Barker, KT
    Waller, J
    Philp, E
    Smith, PD
    Yulug, I
    Peto, J
    Parker, G
    Allday, MJ
    Crompton, MR
    Gusterson, BA
    [J]. ONCOGENE, 1998, 17 (13) : 1681 - 1689
  • [10] Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation
    Deng, CX
    Scott, F
    [J]. ONCOGENE, 2000, 19 (08) : 1059 - 1064